Patient-specific neural progenitor cells derived from induced pluripotent stem cells offer a promise of good models for mitochondrial disease

被引：0
作者：
Xiao Liang
Cecilie Katrin Kristiansen
Guro Helén Vatne
Yu Hong
Laurence Albert Bindoff
机构：
[1] University of Bergen,The Mitochondrial Medicine and Neurogenetics (MMN) Group, Department of Clinical Medicine
[2] Haukeland University Hospital,Department of Neurology
来源：
Cell and Tissue Research | 2020年 / 380卷
关键词：
Neural progenitor cells; Induced pluripotent stem cells; Mitochondrial disease; mtDNA; Disease modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Mitochondria are the primary generators of ATP in eukaryotic cells through the process of oxidative phosphorylation. Mitochondria are also involved in several other important cellular functions including regulation of intracellular Ca2+, cell signaling and apoptosis. Mitochondrial dysfunction causes disease and since it is not possible to perform repeated studies in humans, models are essential to enable us to investigate the mechanisms involved. Recently, the discovery of induced pluripotent stem cells (iPSCs), made by reprogramming adult somatic cells (Takahashi and Yamanaka 2006; Yamanaka and Blau 2010), has provided a unique opportunity for studying aspects of disease mechanisms in patient-specific cells and tissues. Reprogramming cells to neuronal lineage such as neural progenitor cells (NPCs) generated from the neural induction of reprogrammed iPSCs can thus provide a useful model for investigating neurological disease mechanisms including those caused by mitochondrial dysfunction. In addition, NPCs display a huge clinical potential in drug screening and therapeutics.
引用
收藏
页码：15 / 30
页数：15
相关论文
共 868 条
[31]  
Muller FJ(2016)Mitochondrial DNA mutations in iPS cells: mtDNA integrity as standard iPSC selection criteria? EMBO J 35 1960-1025
[32]  
Loring JF(2013)Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model Proc Natl Acad Sci U S A 110 E3622-210
[33]  
Yamasaki TR(2016)Generation and characterization of induced pluripotent stem cells from patients with mtDNA mutations Methods Mol Biol 1353 65-777
[34]  
Poon WW(2015)The evolution of early neurogenesis Dev Cell 32 390-636
[35]  
Green KN(2016)Concise review: heteroplasmic mitochondrial DNA mutations and mitochondrial diseases: toward iPSC-based disease modeling, drug discovery, and regenerative therapeutics Stem Cells 34 801-1971
[36]  
LaFerla FM(2015)Primer retention owing to the absence of RNase H1 is catastrophic for mitochondrial DNA replication Proc Natl Acad Sci U S A 112 9334-382
[37]  
Carling PJ(2000)Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA Cell 100 515-69
[38]  
Cree LM(2013)Polg2 is essential for mammalian embryogenesis and is required for mtDNA maintenance Hum Mol Genet 22 1017-48
[39]  
Chinnery PF(2018)Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome Hum Genome Var 5 25-C669
[40]  
Casarosa S(2009)NDUFS4: creation of a mouse model mimicking a complex I disorder Mitochondrion 9 204-504
12345678910